These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Determination of Pseudoginsengenin DQ in rat plasma by UPLC-MS/MS and application of the method in a pharmacokinetic study.
    Author: Gao H, Li Z, Li P, Lin M, Han L, Wang F, Liu J.
    Journal: J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Aug 15; 933():1-7. PubMed ID: 23845389.
    Abstract:
    Pseudoginsengenin DQ (pseudoginsengenin of diol derivatives quest, PDQ), the product of the oxidative cyclization of protopanaxadiol, exhibits a significant pharmacological effect as an antiarrhythmic agent. A sensitive and rapid analytical method based on ultra-performance liquid chromatography coupled with tandem mass spectrometry (UPLC-MS/MS) was initially developed for the detection of PDQ in rat plasma. Pre-treatment of the sample obtained from the plasma involved a single protein precipitation step, using methanol. PDQ and an internal standard (IS), physcion, were separated on a Waters ACQUITY UPLC BEH C18 analytical column (50mm×2.1mm, 1.7μm) using acetonitrile-0.1% formic acid in water (70:30, v/v) as the mobile phase, at a flow rate of 0.3mL/min. Chromatography of the PDQ and IS was performed within 3min. Detection was performed through positive ion electrospray ionization (ESI(+)) in multiple reaction-monitoring (MRM) mode. The assay was linear over the concentration range of 5-1000ng/mL (r>0.9980). The limit of detection (LOD) and the lower limit of quantification (LLOQ) were 0.5ng/mL and 5.0ng/mL, respectively. The intra- and inter-day deviations (expressed as relative standard deviation, RSD) were ≤9.5% and ≤1.7%, respectively, and the accuracy (expressed as relative error, RE) was in the range of -1.1 to 2.7%. The recoveries of PDQ and IS were 95.2% and 100.7%, respectively, and the matrix effects were satisfactory in all of the biological matrices examined. This fully validated method was successfully applied to the pharmacokinetic study of rats after a single initial intragastric administration of 15mg/kg PDQ. The main pharmacokinetic parameters: Tmax (the time to peak), Cmax (the concentration to peak), and t1/2 (the biological half time) were 4.0±0.0h, 3265.12±700.26ng/mL, 5.97±0.43h, respectively.
    [Abstract] [Full Text] [Related] [New Search]